quinoxalines has been researched along with carbon monoxide in 40 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (17.50) | 18.2507 |
2000's | 23 (57.50) | 29.6817 |
2010's | 10 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hawkins, RD; Kandel, ER; Small, SA; Zhuo, M | 1 |
Brien, JF; Hussain, AS; Marks, GS; Nakatsu, K | 1 |
Alam, J; Choi, AM; Cook, JL; Hartsfield, CL | 1 |
Canning, BJ; Fischer, A | 1 |
Caudill, TK; Kanagy, NL; Resta, TC; Walker, BR | 1 |
Alm, P; Ekström, P; Henningsson, R; Lundquist, I | 1 |
Berni, LA; Gai, P; Mannaioni, PF; Masini, E; Mirabella, C; Ndisang, JF | 1 |
Hanna, ST; Peterson-Wakeman, R; Wang, R; Wang, Z; Wu, L | 1 |
Ahn, D; Chung, S; Kwon, S; Nam, T; Yeon, D | 1 |
Borsody, MK; Komuro, T; Macdonald, RL; Marton, LS; Ono, S; Paik, E; Weir, BK; Zhang, ZD | 1 |
Naik, JS; Walker, BR | 1 |
Söderberg, BC; Tamariz, J; Wallace, JM | 1 |
Jang, CG; Kim, JH; Lee, SJ; Lee, SY; Sohn, UD; Yang, SI | 1 |
Chapman, GB; Durante, W; Liu, XM; Peyton, KJ; Schafer, AI | 1 |
Choi, AM; Kaizu, T; Kimizuka, K; Murase, N; Nakao, A; Nalesnik, MA; Neto, JS; Otterbein, LE; Stolz, DB; Uchiyama, T; Zuckerbraun, BS | 1 |
Barkoudah, E; Jaggar, JH; Leffler, CW | 1 |
Britigan, BE; Giriyappa, RL; Husted, RF; Stokes, JB; Uc, A | 1 |
Balabanova, L; Fedinec, AL; Leffler, CW; Parfenova, H | 1 |
Abraham, NG; Bolognesi, M; Di Pascoli, M; Rodella, L; Sacerdoti, D; Turkseven, S | 1 |
Foresti, R; Fuller, BJ; Green, CJ; Mann, BE; Motterlini, R; Sandouka, A | 1 |
Allanson, M; Domanski, D; Reeve, VE | 1 |
Drummond, HA; Gadepalli, RS; Jernigan, NL; McLemore, GR; Poreddy, SR; Rimoldi, JM; Ryan, MJ; Stec, DE | 1 |
Chlopicki, S; Lomnicka, M; Marcinkiewicz, E; Motterlini, R; Olszanecki, R | 1 |
Abraham, NG; Bolognesi, M; Di Pascoli, M; Gatta, A; McGiff, JC; Sacerdoti, D; Schwartzman, ML | 1 |
Botros, FT; Navar, LG | 1 |
Farrugia, G; Harmsen, WS; Sha, L; Szurszewski, JH | 1 |
Brouckaert, P; Buys, E; De Backer, O; Elinck, E; Lefebvre, RA; Sips, P | 1 |
Glaser, PE; Rush, CR; Stoops, WW; Vansickel, AR | 1 |
Alves, PM; Queiroga, CS; Vieira, HL | 1 |
Hering, T | 1 |
Antunes-Rodrigues, J; Cunha, FQ; Elias, LL; Giusti-Paiva, A; Gomes, DA; Ventura, RR | 1 |
Arteaga, C; Brandon, TH; Gonzales, D; Jorenby, DE; Lee, TC | 1 |
Bahk, JH; Kim, SJ; Park, SJ; Yoo, HY | 1 |
Jao, NC; Karelitz, JL; Perkins, KA | 1 |
Davis, R; Kmetova, A; Kralikova, E; Stepankova, L; West, R; Zvolska, K | 1 |
Anderson, BJ; Audet, D; Caviness, CM; Kurth, ME; Olson, J; Stein, MD | 1 |
Pezzuto, A; Spoto, C; Tonini, G; Vincenzi, B | 1 |
Abdool-Gaffar, MS; Bateman, ED; Bruning, A; Emanuel, S; Esterhuizen, TM; Irusen, EM; Koegelenberg, CF; Noor, F; O'Brien, JA; Smith, C; van Zyl-Smit, RN | 1 |
Artinian, L; Estes, S; Rehder, V | 1 |
Birulina, YG; Gusakova, SV; Kovalev, IV; Nosarev, AV; Petrova, IV; Rydchenko, VS; Smagliy, LV; Yartseva, YO | 1 |
4 trial(s) available for quinoxalines and carbon monoxide
Article | Year |
---|---|
Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo.
Topics: Adolescent; Adult; Aged; Benzazepines; Breath Tests; Bupropion; Carbon Monoxide; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Drug Labeling; Female; Health Knowledge, Attitudes, Practice; Humans; Logistic Models; Male; Middle Aged; Motivation; Nicotinic Agonists; Placebos; Quinoxalines; Secondary Prevention; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome; Varenicline; Young Adult | 2010 |
Optimal carbon monoxide criteria to confirm 24-hr smoking abstinence.
Topics: Adult; Benzazepines; Carbon Monoxide; Cross-Over Studies; Female; Humans; Male; Nicotinic Agonists; Prospective Studies; Quinoxalines; Reward; Sensitivity and Specificity; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Products; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult | 2013 |
Varenicline for smoking cessation among methadone-maintained smokers: a randomized clinical trial.
Topics: Adult; Benzazepines; Carbon Monoxide; Female; Follow-Up Studies; Guideline Adherence; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Narcotics; Opiate Substitution Treatment; Patient Compliance; Quinoxalines; Smoking Cessation; Socioeconomic Factors; Tobacco Use Disorder; Varenicline | 2013 |
Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial.
Topics: Adult; Benzazepines; Breath Tests; Carbon Monoxide; Cholinergic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2014 |
36 other study(ies) available for quinoxalines and carbon monoxide
Article | Year |
---|---|
Nitric oxide and carbon monoxide produce activity-dependent long-term synaptic enhancement in hippocampus.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Carbon Monoxide; Electric Stimulation; Guinea Pigs; Hippocampus; In Vitro Techniques; Male; Membrane Potentials; Nitric Oxide; Protoporphyrins; Quinoxalines; Signal Transduction; Synapses | 1993 |
The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-alpha]quinoxalin-1-one (ODQ) inhibits relaxation of rabbit aortic rings induced by carbon monoxide, nitric oxide, and glyceryl trinitrate.
Topics: Animals; Aorta; Carbon Monoxide; Enzyme Inhibitors; Guanylate Cyclase; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Nitroglycerin; Oxadiazoles; Quinoxalines; Rabbits | 1997 |
Regulation of heme oxygenase-1 gene expression in vascular smooth muscle cells by nitric oxide.
Topics: Animals; Aorta; Carbon Monoxide; Cell Nucleus; Cells, Cultured; Cyclic GMP; Dactinomycin; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Guanylate Cyclase; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Kinetics; Muscle, Smooth, Vascular; Nitric Oxide; Nitrogen Oxides; Oligonucleotide Probes; Oxadiazoles; Quinoxalines; Rats; RNA Processing, Post-Transcriptional; RNA, Messenger; Spermine; Transcription, Genetic | 1997 |
Localization of heme oxygenase-2 immunoreactivity to parasympathetic ganglia of human and guinea-pig airways.
Topics: Animals; Atropine; Carbon Monoxide; Cyclic GMP; Enzyme Inhibitors; Female; Ganglia, Parasympathetic; Ganglionic Blockers; Guanylate Cyclase; Guinea Pigs; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Humans; Membrane Proteins; Muscarinic Antagonists; Muscle Contraction; Oxadiazoles; Protoporphyrins; Quinoxalines; Receptors, Cholinergic; Respiratory Physiological Phenomena; Respiratory System; Synaptic Transmission; Trimethaphan; Vagus Nerve | 1998 |
Role of endothelial carbon monoxide in attenuated vasoreactivity following chronic hypoxia.
Topics: Animals; Aorta, Thoracic; Arsenites; Carbon Monoxide; Endothelium, Vascular; Enzyme Inhibitors; Guanylate Cyclase; Heme Oxygenase (Decyclizing); Hypoxia; In Vitro Techniques; Kinetics; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nitric Oxide Donors; Nitroarginine; Oxadiazoles; Penicillamine; Phenylephrine; Protoporphyrins; Quinoxalines; Rats; Rats, Sprague-Dawley; Reference Values; S-Nitroso-N-Acetylpenicillamine; Sodium Compounds | 1998 |
Heme oxygenase and carbon monoxide: regulatory roles in islet hormone release: a biochemical, immunohistochemical, and confocal microscopic study.
Topics: Animals; Blotting, Western; Carbon Monoxide; Cyclic GMP; Drug Interactions; Enzyme Inhibitors; Female; Glucose; Heme Oxygenase (Decyclizing); Hemin; Hormones; Immunohistochemistry; Islets of Langerhans; Mice; Mice, Inbred Strains; Microscopy, Confocal; Nitric Oxide; Oxadiazoles; Protoporphyrins; Quinoxalines | 1999 |
Modulation of the immunological activation of human basophils by carbon monoxide.
Topics: Basophils; Carbon Monoxide; Enzyme Inhibitors; Guanylate Cyclase; Heme Oxygenase (Decyclizing); Hemin; Histamine Release; Humans; Oxadiazoles; Oxyhemoglobins; Quinoxalines | 1999 |
Reduced vasorelaxant effect of carbon monoxide in diabetes and the underlying mechanisms.
Topics: 3-O-Methylglucose; Animals; Arteries; Calcium; Carbon Monoxide; Cells, Cultured; Cyclic GMP; Diabetes Mellitus, Experimental; Glucose; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Oxadiazoles; Potassium Channels; Quinoxalines; Rats; Rats, Sprague-Dawley; Reference Values; Tail; Time Factors; Vasodilation; Vasodilator Agents | 2001 |
Mechanism of carbon monoxide-induced relaxation in the guinea pig ileal smooth muscle.
Topics: Animals; Calcium; Calcium Channels; Carbon Monoxide; Cyclic GMP; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Fluorescent Dyes; Fura-2; Guinea Pigs; Ileum; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth; Oxadiazoles; Patch-Clamp Techniques; Potassium Chloride; Quinoxalines; Signal Transduction | 2001 |
The vasorelaxation of cerebral arteries by carbon monoxide.
Topics: Animals; Carbon Monoxide; Cerebral Arteries; Dinoprost; Dogs; Enzyme Inhibitors; Guanylate Cyclase; In Vitro Techniques; Muscle Contraction; Oxadiazoles; Potassium Channel Blockers; Potassium Chloride; Quinoxalines; Tetraethylammonium; Vasodilation | 2001 |
Homogeneous segmental profile of carbon monoxide-mediated pulmonary vasodilation in rats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Carbon Monoxide; Cyclic GMP; Dipyridamole; Enzyme Inhibitors; Heme Oxygenase (Decyclizing); Hypertension, Pulmonary; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Oxadiazoles; Peptides; Phosphodiesterase Inhibitors; Potassium Channel Blockers; Pulmonary Circulation; Quinoxalines; Rats; Rats, Sprague-Dawley; Tetraethylammonium; Vascular Resistance; Vasodilation | 2001 |
A novel palladium-catalyzed synthesis of 1,2-dihydroquinoxalines and 3,4-dihydroquinoxalinones.
Topics: Carbon Monoxide; Catalysis; Crystallography, X-Ray; Indicators and Reagents; Oxidation-Reduction; Palladium; Quinoxalines | 2002 |
Carbon monoxide as a novel central pyrogenic mediator.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Temperature; Body Temperature Regulation; Carbon Monoxide; Cerebrospinal Fluid; Dibutyryl Cyclic GMP; Enzyme Inhibitors; Guanylate Cyclase; Heme Oxygenase (Decyclizing); Hemin; Hypothalamus; Indomethacin; Injections, Intraventricular; Male; Oxadiazoles; Protoporphyrins; Quinoxalines; Rats; Rats, Sprague-Dawley | 2002 |
Antiapoptotic action of carbon monoxide on cultured vascular smooth muscle cells.
Topics: Animals; Apoptosis; Carbon Monoxide; Caspase 3; Caspases; Cells, Cultured; Cytokines; DNA Fragmentation; Enzyme Inhibitors; Imidazoles; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Oxadiazoles; Pyridines; Quinoxalines; Rats | 2003 |
Carbon monoxide inhalation protects rat intestinal grafts from ischemia/reperfusion injury.
Topics: Administration, Inhalation; Animals; Blood Vessels; Carbon Monoxide; Carboxyhemoglobin; Corrosion Casting; Cytokines; Enzyme Inhibitors; Gases; Guanylate Cyclase; Inflammation Mediators; Intestine, Small; Ischemia; Male; Osmolar Concentration; Oxadiazoles; Plasminogen Activator Inhibitor 1; Platelet Endothelial Cell Adhesion Molecule-1; Quinoxalines; Rats; Rats, Inbred Lew; Regional Blood Flow; Reperfusion Injury; RNA, Messenger; Survival Analysis | 2003 |
The permissive role of endothelial NO in CO-induced cerebrovascular dilation.
Topics: Animals; Arterioles; Carbon Monoxide; Cerebral Arteries; Cyclic GMP; Endothelium, Vascular; Enzyme Inhibitors; Female; Male; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroarginine; Nitroprusside; Oxadiazoles; Pia Mater; Potassium Channel Blockers; Quinoxalines; Swine; Tetraethylammonium; Vasodilation | 2004 |
Hemin induces active chloride secretion in Caco-2 cells.
Topics: Caco-2 Cells; Carbon Monoxide; Chlorides; Cyclic AMP; Cyclic GMP; Enzyme Inhibitors; Epithelium; Hemin; Homeostasis; Humans; Ouabain; Oxadiazoles; Quinoxalines; Sodium; Water-Electrolyte Balance | 2005 |
Nitric oxide increases carbon monoxide production by piglet cerebral microvessels.
Topics: Animals; Animals, Newborn; Carbon Monoxide; Cerebrovascular Circulation; Enzyme Inhibitors; Guanylate Cyclase; Imidazoles; Microcirculation; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroarginine; Nitroprusside; Oxadiazoles; Quinoxalines; Swine | 2005 |
Chronic CO levels have [corrected] a beneficial effect on vascular relaxation in diabetes.
Topics: Acetylcholine; Animals; Aorta; Biliverdine; Blotting, Western; Carbon Monoxide; Chromium; Densitometry; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Endothelium, Vascular; Femoral Artery; Guanylate Cyclase; Heme; Immunohistochemistry; Male; Mesoporphyrins; Muscle Contraction; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Organometallic Compounds; Oxadiazoles; Oxidative Stress; Protoporphyrins; Pyrazines; Pyrroles; Quinoxalines; Rats; Rats, Sprague-Dawley; Stress, Mechanical; Time Factors | 2006 |
Treatment with CO-RMs during cold storage improves renal function at reperfusion.
Topics: Animals; Carbon Monoxide; Cold Temperature; Kidney; Male; Mitochondria; Organ Preservation; Oxadiazoles; Oxygen Consumption; Quinoxalines; Rabbits; Reperfusion Injury | 2006 |
Photoimmunoprotection by UVA (320-400 nm) radiation is determined by UVA dose and is associated with cutaneous cyclic guanosine monophosphate.
Topics: Animals; Carbon Monoxide; Cyclic GMP; Dermatitis, Contact; Dose-Response Relationship, Radiation; Enzyme Activation; Female; Guanylate Cyclase; Immune Tolerance; Mice; Mice, Inbred Strains; Oxadiazoles; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Quinoxalines; Sildenafil Citrate; Skin; Sulfones; Ultraviolet Rays | 2006 |
Renal vascular responses to CORM-A1 in the mouse.
Topics: Animals; Boranes; Carbon Monoxide; Carbonates; Carboxyhemoglobin; Female; Guanylate Cyclase; In Vitro Techniques; Kidney; Male; Mice; Mice, Inbred C57BL; Oxadiazoles; Potassium Channels, Calcium-Activated; Quinoxalines; Renal Artery; Renal Circulation; Vascular Resistance; Vasodilation | 2006 |
Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
Topics: Analysis of Variance; Blood Platelets; Carbon Monoxide; Collagen; Dose-Response Relationship, Drug; Guanylate Cyclase; Humans; Indazoles; Nitric Oxide Donors; Organometallic Compounds; Oxadiazoles; Penicillamine; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Quinoxalines; Spectrophotometry; Statistics, Nonparametric; Thrombin; Time Factors | 2006 |
Rat mesenteric arterial dilator response to 11,12-epoxyeicosatrienoic acid is mediated by activating heme oxygenase.
Topics: 8,11,14-Eicosatrienoic Acid; Acetylcholine; Animals; Carbon Monoxide; Dose-Response Relationship, Drug; Heme Oxygenase (Decyclizing); Male; Mesenteric Arteries; Mesoporphyrins; Organometallic Compounds; Oxadiazoles; Peptides; Potassium Channels, Calcium-Activated; Quinoxalines; Rats; Rats, Wistar; Vasodilation; Vasodilator Agents | 2006 |
Interaction between endogenously produced carbon monoxide and nitric oxide in regulation of renal afferent arterioles.
Topics: Animals; Arterioles; Carbon Monoxide; Enzyme Inhibitors; Guanylate Cyclase; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Kidney; Male; Mesoporphyrins; Microcirculation; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Oxadiazoles; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Renal Circulation; Soluble Guanylyl Cyclase; Vasoconstriction; Vasodilation | 2006 |
Membrane potential gradient is carbon monoxide-dependent in mouse and human small intestine.
Topics: Animals; Carbon Monoxide; Enzyme Inhibitors; Guanylate Cyclase; Heme Oxygenase (Decyclizing); Humans; In Vitro Techniques; Intestine, Small; Membrane Potentials; Mesoporphyrins; Mice; Mice, Knockout; Mice, Neurologic Mutants; Muscle, Smooth; Nitric Oxide Synthase; Nitroarginine; Oxadiazoles; Oxyhemoglobins; Quinoxalines; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase; Tetrodotoxin | 2007 |
Role of the soluble guanylyl cyclase alpha1/alpha2 subunits in the relaxant effect of CO and CORM-2 in murine gastric fundus.
Topics: Animals; Carbon Monoxide; Cyclic GMP; Gastric Fundus; Guanylate Cyclase; Indazoles; Male; Mice; Mice, Knockout; Organometallic Compounds; Oxadiazoles; Protein Subunits; Quinoxalines; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase | 2008 |
The influence of acute varenicline administration on smoking and eating behavior in humans.
Topics: Adult; Benzazepines; Carbon Monoxide; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Feeding Behavior; Female; Humans; Male; Methylphenidate; Quinoxalines; Smoking; Surveys and Questionnaires; Varenicline | 2008 |
Pre-conditioning induced by carbon monoxide provides neuronal protection against apoptosis.
Topics: Animals; Animals, Newborn; Apoptosis; Carbon Monoxide; Cells, Cultured; Cerebellum; Decanoic Acids; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glutamic Acid; Hydroxy Acids; Metalloporphyrins; Mice; Neurons; NG-Nitroarginine Methyl Ester; Oxadiazoles; Oxidative Stress; Quinoxalines; Reactive Oxygen Species; tert-Butylhydroperoxide; Time Factors | 2008 |
[Specific program for smoking cessation: thus your patients become nonsmokers].
Topics: Behavior Therapy; Benzazepines; Bupropion; Carbon Monoxide; Contraindications; Humans; Nicotinic Agonists; Physician-Patient Relations; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2008 |
Carbon monoxide and nitric oxide modulate hyperosmolality-induced oxytocin secretion by the hypothalamus in vitro.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Carbon Monoxide; Enzyme Inhibitors; Hypothalamus; Male; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitrites; Nitroprusside; Osmotic Pressure; Oxadiazoles; Oxytocin; Quinoxalines; Rats; Rats, Wistar | 2010 |
Inhibition of hypoxic pulmonary vasoconstriction of rats by carbon monoxide.
Topics: Animals; Carbon Monoxide; Guanylate Cyclase; Hypoxia; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Oxadiazoles; Pulmonary Artery; Quinoxalines; Rats; Tetraethylammonium; Vasoconstriction | 2010 |
Fifty-two-week continuous abstinence rates of smokers being treated with varenicline versus nicotine replacement therapy.
Topics: Benzazepines; Breath Tests; Carbon Monoxide; Drug Administration Routes; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Prospective Studies; Quinoxalines; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2013 |
Short-term effectiveness of smoking-cessation treatment on respiratory function and CEA level.
Topics: Benzazepines; Carbon Monoxide; Carboxyhemoglobin; Carcinoembryonic Antigen; Combined Modality Therapy; Cough; Counseling; Dyspnea; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Nicotinic Agonists; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline; Vital Capacity | 2013 |
Modulation of growth cone filopodial length by carbon monoxide.
Topics: Action Potentials; Animals; Calcium; Carbazoles; Carbon Monoxide; Enzyme Inhibitors; Ganglia, Invertebrate; Growth Cones; Heme Oxygenase-1; Neurons; Nitric Oxide; Organometallic Compounds; Oxadiazoles; Oxazines; Patch-Clamp Techniques; Pseudopodia; Quinoxalines; Signal Transduction; Snails; Time Factors | 2017 |
Role of Carbon Monoxide in the Mechanisms of Action of Extracellular ATP on Contractile Activity of Vascular Smooth Muscle Cells.
Topics: Adenosine Triphosphate; Animals; Aorta; Carbon Monoxide; Cells, Cultured; Endothelium; Muscle Contraction; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Organometallic Compounds; Oxadiazoles; Phenylephrine; Protoporphyrins; Purinergic P2X Receptor Agonists; Purinergic P2Y Receptor Agonists; Quinoxalines; Rats; Rats, Wistar; Receptors, Purinergic P2X; Receptors, Purinergic P2Y | 2019 |